BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,668,286 | -28.4% | 2,837,924 | -1.4% | 0.04% | -32.8% |
| Q4 2022 | $33,044,342 | -1.0% | 2,878,427 | +8.6% | 0.06% | -1.7% |
| Q3 2022 | $33,385,000 | +8.2% | 2,649,616 | -9.2% | 0.06% | +13.5% |
| Q2 2022 | $30,864,000 | -33.2% | 2,917,209 | +2.7% | 0.05% | -14.8% |
| Q1 2022 | $46,201,000 | +17.4% | 2,841,405 | +0.0% | 0.06% | +29.8% |
| Q4 2021 | $39,351,000 | -4.0% | 2,841,230 | -0.4% | 0.05% | -6.0% |
| Q3 2021 | $40,974,000 | -17.6% | 2,851,384 | -9.3% | 0.05% | -15.3% |
| Q2 2021 | $49,699,000 | +61.5% | 3,143,485 | +3.9% | 0.06% | +51.3% |
| Q1 2021 | $30,770,000 | – | 3,025,606 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |